Observational studyArquivos de gastroenterologia2026
CLINICAL PREDICTORS OF CHOLEDOCHOLITHIASIS IN MILD ACUTE BILIARY PANCREATITIS: DEVELOPMENT OF AN EXPLORATORY RISK STRATIFICATION MODEL.
Observational study in Arquivos de gastroenterologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute biliary pancreatitis is one of the most common forms of acute pancreatitis and is frequently associated with transient or persistent common bile duct stones. When not promptly recognized, choledocholithiasis may result in severe complications such as cholangitis and recurrent pancreatitis. Early identification of patients at higher risk for concomitant choledocholithiasis, based on clinical and laboratory findings, is essential to guide timely diagnostic and therapeutic interventions while avoiding unnecessary procedures and costs.
objectiveTo evaluate clinical and laboratory predictors associated with choledocholithiasis in patients with mild acute biliary pancreatitis and to develop an exploratory risk stratification model based on routinely available clinical variables.
methodsA retrospective observational cohort study was conducted through review of medical records and imaging studies of patients admitted to the Central Emergency Department of Santa Casa de São Paulo between January 2017 and August 2024 with mild acute biliary pancreatitis according to the revised Atlanta classification.
resultsA total of 630 medical records were screened, and 145 patients with mild acute biliary pancreatitis met inclusion criteria, with the mean age of 48 years. Among the patients, 65.5% were female. Patients with confirmed choledocholithiasis had significantly higher total bilirubin levels at admission and after 48 hours (P=0.001). Alkaline phosphatase levels were also significantly higher in the stone group (P=0.011), whereas gamma-glutamyl transferase showed no significant difference (P=0.115). Gallstone size did not differ between groups (P=0.936). A logistic regression model demonstrated approximately 80% accuracy (AUROC 0.80), based on age ≥65 years, day-2 total bilirubin ≥2.4 mg/dL, and alkaline phosphatase ≥183 U/L. Internal validation using bootstrap resamples demonstrated a AUROC of 0.793. The calibration slope was 1.33, with an intercept of 0.24 and Brier score of 0.126.
conclusionA simple clinical prediction model based on older age, persistent bilirubin elevation, and elevated alkaline phosphatase demonstrated acceptable discrimination to associate choledocholithiasis in patients with mild acute biliary pancreatitis and reasonable internal calibration after bootstrap validation, with particular usefulness for identifying patients at low probability of choledocholithiasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.